Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trafermin in marginal periodontitis
NCT00199290Phase 2Completed
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Aug 2005
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of trafermin in periodontitis, sponsored by Kaken Pharmaceutical Co., Ltd.. Started Aug 2005; status: completed.
02
Drugs
trafermin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT00199290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199290.